• Cronos Group (CRON) has released a new set of marketing principles guided by the belief that those below the legal age of consumption should not be targeted in an adult-use cannabis market
  • The company encourages other cannabis companies and policymakers to adopt these principles across all types of marketing and advertising
  • CEO Kurt Schmidt calls the new marketing code “an important step toward elevating industry practices”
  • Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development
  • Cronos Group (CRON) is down 4.81 per cent on the day and is trading at $8.91 per share

Cronos Group (CRON) has released a code of conduct regarding marketing campaigns.

These principles are guided by the belief that those below the legal age of consumption should not be targeted in an adult-use cannabis market.

The company recognized the need for standards in cannabis marketing and has created its own standards that will be publicly shared as a resource for the cannabis industry and policymakers.

The Cronos Group “Marketing Code” intends to uphold the following principles:

  • Advertising will be targeted to adults
  • Cronos Group will highlight responsible cannabis consumption and any people depicted in any imagery will be adults
  • Brand websites and social media will be designed for adults
  • Marketing events will be targeted to adults and will promote responsible cannabis consumption
  • The company will provide its customers with facts and substantiate its claims

Kurt Schmidt, president and CEO of Cronos Group, commented,

“This Marketing Code is an important step toward elevating industry practices. We hope that others within the industry will embrace similar commitments.”

He added,

“As policymakers consider how to best regulate a federally legal U.S. cannabis market, we believe these principles reflect the sort of policies necessary to support a trustworthy industry.”

The company is actively implementing the training and protocols necessary to uphold these commitments and intends to live these values through its advertising, imagery, websites, social media, and marketing events.

Anna Shlimak, senior VP of corporate affairs at Cronos Group, commented,

“In the coming weeks and months, Cronos Group will be working with our industry peers in the U.S. to advance these important measures. We call on like-minded cannabis companies to join us. We will also be engaging with policymakers and regulators to share the expertise we’ve developed through operating in the strictly regulated Canadian market for close to a decade.”

Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents.

The company is committed to building disruptive intellectual property by advancing cannabis research, technology and product development.

Cronos Group (CRON) is down 4.81 per cent on the day and is trading at $8.91 per share as of 11:44 am ET. 

More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.